Zdrowie i gospodarka · 17/12/2020

FDA Releases Final Guidance on Controlled Correspondence for Generic Drug Development

The Food and Drug Administration (FDA) has released a final guidance for industry on controlled correspondence related to generic drug development, replacing a previous 2015 guidance. The new guidance provides information on submitting requests for clarification and the FDA's response process.